The severe respiratory consequences of the coronavirus disease 2019 (COVID-19)
pandemic have prompted urgent need for novel therapies. Cell-based approaches, primarily …

Acute respiratory distress syndrome (ARDS) is characterized by the severe inflammation
and destruction of the lung air–blood barrier, leading to irreversible and substantial …

The aim of this clinical trial was to control the cytokine storm by administering mesenchymal
stem cells (MSCs) to critically-ill COVID-19 patients, to evaluate the healing effect, and to …

Acute respiratory distress syndrome (ARDS) represents a significant burden to the
healthcare system, with≈ 200 000 cases diagnosed annually in the USA. ARDS patients …

The 2019 novel coronavirus disease (COVID-19), caused by the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), has occurred in China and around the world. SARS …

As a result of cross-species transmission in December 2019, the coronavirus disease 2019
(COVID-19) became a serious endangerment to human health and the causal agent of a …

Ethyl ferulate (EF) is abundant in Rhizoma Chuanxiong and grains (eg, rice and maize) and
possesses antioxidative, antiapoptotic, antirheumatic, and anti-inflammatory properties …

Acute lung injury (ALI), an increasingly devastating human disorder, is characterized by a
multitude of lung changes arising from a wide variety of lung injuries. Viral infection is the …

The recent coronavirus disease-2019 (COVID-19) outbreak has increased at an alarming
rate, representing a substantial cause of mortality worldwide. Respiratory injuries are major …

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-caused coronavirus
disease 2019 (COVID-19) pandemic has become a global health crisis with an extremely …